In other studies, NORAD is considered a tumor suppressor as its expression levels are lower in BC tissues and cancer cells compared to normal conditions, leading to increased cell proliferation, migration and invasion, LNM development and poor prognosis [38,39]. Here, NORAD is linked to breast cancer.